Indeed, the proportion of BRCA1- and BRCA2-deficient breast cancers with biallelic pathogenic germline mutations was significantly higher in WSI compared to TCGA whereas the proportion of BRCA1- and BRCA2-deficient breast cancers with biallelic pathogenic somatic mutations was not significantly different between the two cohorts. The gene discussed is BRCA1; the disease is breast carcinoma.